Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of CYR61-treated THP1 human monocytes

ABSTRACT: RNA-seq of CYR61-treated THP1 human monocytes

PROVIDER: PRJNA975085 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24686617_1.fastq.gz	Fastqsanger.gz
	SRR24686617_2.fastq.gz	Fastqsanger.gz
	SRR24686618_1.fastq.gz	Fastqsanger.gz
	SRR24686618_2.fastq.gz	Fastqsanger.gz
	SRR24686619_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 40

Similar Datasets

RNA-seq of CYR61-treated THP1 human monocytes

Project description:We assess the effects of CYR61 treatment on the transcriptome of human THP1 monocytes.

2023-10-18 | GSE233125 | GEO

Bulk RNA-seq of: HUVECs co-incubated with CYR61-treated mouse bone marrow-derived macrophages CYR61-treated murine bone marrow-derived macrophages CYR61-treated HUVECs and CYR61-treated human THP1 monocytes

Project description:Bulk RNA-seq of: HUVECs co-incubated with CYR61-treated mouse bone marrow-derived macrophages CYR61-treated murine bone marrow-derived macrophages CYR61-treated HUVECs and CYR61-treated human THP1 monocytes

| PRJNA917714 | ENA

Quantitative proteomic analysis of human monocytes (THP1)

Project description:To observe the changes of protein expression in human monocytes (THP1) infected with adenovirus.

2023-02-06 | PXD039874 |

Genes regulated by CREB1 in LPS-primed THP1 monocytes

Project description:To screen the genes and pathways regulated by CREB1 in the THP1 monocytes induced by LPS, THP1 monocytes were transfected by CREB1 shRNA and then treated by LPS for 3 hours.

2023-04-14 | GSE229580 | GEO

Decoding the gene promoters binding with BRD3 in LPS-primed THP1 monocytes

Project description:To screen the genes regulated by BRD3 in the THP1 monocytes induced by LPS, THP1 monocytes were treated by LPS for 1 hour in the presence or absence of OTX015

2023-12-31 | GSE234162 | GEO

RNA-seq of CYR61-treated human umbilical vein endothelial cells

Project description:RNA-seq of CYR61-treated human umbilical vein endothelial cells

| PRJNA917719 | ENA

RNA-seq of CYR61-treated human umbilical vein endothelial cells

Project description:We assess the effect of CYR61 treatment on the transcriptome of human umbilical vein endothelial cells.

2023-10-18 | GSE222101 | GEO

Chip-chip from THP1 cells with Pol II, Pol II Ser5-P, H3K9Ac and from primary monocytes with H3K4Me3

Project description:THP1 cells were ChIPed with indicated antibodies. Comparison of selected chromatin marks in THP1 cells and monocytes

2013-02-15 | E-GEOD-43870 | biostudies-arrayexpress

RNA-Sequencing Analysis of High Glucose Treated Monocytes Reveals Novel Transcriptome Signatures and associated Epigenetic Profiles

Project description:We report high throughput transcriptomic profiling with RNA-Sequencing (RNA-Seq) to uncover network responses in human THP-1 monocytes treated with high glucose (HG). Examination of differential expression between normal and high glucose condition in THP1 cells.

2013-02-15 | E-GEOD-43925 | biostudies-arrayexpress

CYR61 orchestrates NASH fibrosis through SYK-NFκB-PDGF signaling in monocyte-derived macrophages [bulk RNA-seq]

Project description:Obesity is increasing worldwide and leads to a multitude of metabolic diseases including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatosis (NASH). Here we examine the role of CYR61 in liver fibrosis and inflammation and its potential as a therapeutic target. Loss of CYR61 during NASH injury improves glucose tolerance, decreases liver inflammation and reduces fibrosis. CYR61 activates signaling in monocytes and monocyte-derived macrophages promoting a pro-inflammatory/pro-fibrotic phenotype through a CYR61/SYK/NFKB signaling cascade. In vitro, CYR61 activates Pdgfa and Pdgfb expression in macrophages in a NFκB-dependent manner. Ultimately, we identify a potential therapeutic for NASH: a CYR61-blocking antibody that reduces fibrotic injury and CYR61-driven signaling in macrophages in vitro and in vivo. This study demonstrates that CYR61 is a key driver of liver inflammation and fibrosis and a strong therapeutic target for treatment of NAFLD/NASH.

2023-10-02 | GSE199637 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data